Adenovirus-mediated gene expression in vivo is enhanced by the antiapoptotic Bcl-2 gene

Journal of Virology

Volumn 73, Issue 8, 1999, Pages 6992-7000

  Bilbao, Guadalupe ^a   Contreras, Juan L ^b   Zhang, Huang Ge ^c   Pike, M Joyce ^d   Overturf, Ken ^a   Mikheeva, Galina ^a   Krasnykh, Victor ^a   Curiel, David T ^a,e  

^a UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^b Kentucky   (United States)

^c University of Alabama at Birmingham   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e Gene Therapy Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY; PROTEIN BCL 2; VIRUS VECTOR;

ADENOVIRUS; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PROTECTION; GENE EXPRESSION; GENE THERAPY; IMMUNE RESPONSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENE;

EID: 0032809227     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.8.6992-7000.1999     Document Type: Article

References (82)

1. Afonso, C. L., J. G. Neilan, G. F. Kutish, and D. L. Rock. 1996. An African swine fever virus Bcl-2 homolog, 5-HL, suppresses apoptotic cell death. J. Virol. 70:4858-4863.
2. Albert, M. L., B. Sauter, and N. Bhardwaj. 1998. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 392:86-89.
3. Barr, D., J. Tubb, D. Ferguson, A. Scaria, A. Lieber, C. Wilson, J. Perkins, and M. A. Kay. 1995. Strain related variations in adenovirally mediated transgene expression from mouse hepatocytes in vivo: comparisons between immunocompetent and immunodeficient inbred strains. Gene Ther. 2:151-155.
4. Billon, N., L. A. van Grunsven, and B. B. Rudkin. 1996. The CDK inhibitor p21WAF1/Cip1 is induced through a p300-dependent mechanism during NGF-mediated neuronal differentiation of PC12 cells. Oncogene 13:2047-2054.
5. Blom, W. M., B. H. De, I. Meijerman, P. J. Kuppen, G. J. Mulder, and J. F. Nagelkerke. 1999. Interleukin-2-activated natural killer cells can induce both apoptosis and necrosis in rat hepatocytes. Hepatology 29:785-792.
6. Bonnotte, B., N. Favre, M. Moutet, A. Fromentin, E. Solary, M. Martin, and F. Martin. 1998. Bcl-2-mediated inhibition of apoptosis prevents immunogenicity and restores tumorigenicity of spontaneously regressive tumors. J. Immunol. 161:1433-1438.
7. Camargo, C. A. J., J. F. Madden, W. Gao, R. S. Selvan, and P. A. Clavien. 1997. Interleukin-6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent. Hepatology 26:1513-1520.
8. Chiou, S. K., C. C. Tseng, L. Rao, and E. White. 1994. Functional complementation of the adenovirus EIB 19-kilodalton protein with Bcl-2 in the inhibition of apoptosis in infected cells. J. Virol. 68:6553-6566.
9. Chiu, V. K., C. M. Walsh, C. C. Liu, J. C. Reed, and W. R. Clark. 1995. Bcl-2 blocks degranulation but not fas-based cell-mediated cytotoxicity. J. Immunol. 154:2023-2032.
10. Chou, J., and B. Roizman. 1992. The gamma 1(34.5) gene of herpes simplex virus 1 precludes neuroblastoma cells from triggering total shutoff of protein synthesis characteristic of programed cell death in neuronal cells. Proc. Natl. Acad. Sci. USA 89:3266-3270.
11. Clem, R. J., M. Fechheimer, and L. K. Miller. 1991. Prevention of apoptosis by a baculovirus gene during infection of insect cells. Science 254:1388-1390.
12. Clesham, G. J., P. J. Adam, D. Proudfoot, P. D. Flynn, S. Efstathiou, and P. L. Weissberg. 1998. High adenoviral loads stimulate NF kappaB-dependent gene expression in human vascular smooth muscle cells. Gene Ther. 5:174-180.
13. DeMatteo, R. P., G. Chu, M. Ahn, E. Chang, C. Burke, S. E. Raper, C. F. Barker, and J. F. Markmann. 1997. Immunologic barriers to hepatic adenoviral gene therapy for transplantation. Transplantation 63:315-319.
14. Douglas, J. T., and D. T. Curiel. 1997. Adenoviruses as vectors for gene therapy. Sci. Med. 4:44-53.
15. Fisher, K. J., H. Choi, J. Burda, S. J. Chen, and J. M. Wilson. 1996. Recombinant adenovirus deleted of all viral genes for gene therapy of cystic fibrosis. Virology 217:11-22.
16. Garcia, I., I. Martinou, Y. Tsujimoto, and J. C. Martinou. 1992. Prevention of programmed cell death of sympathetic neurons by the bcl-2 proto-oncogene. Science 258:302-304.
17. Gooding, L. R. 1994. Regulation of TNF-mediated cell death and inflammation by human adenoviruses. Infect. Agents Dis. 3:106-115.
18. Han, J., H. D. Wallen, G. Nunez, and E. White. 1998. E1B 19,000-molecular-weight protein interacts with and inhibits CED-4-dependent, FLICE-mediated apoptosis. Mol. Cell. Biol. 18:6052-6062.
19. Henderson, S., M. Rowe, C. Gregory, D. Croom-Carter, F. Wang, R. Longnecker, E. Kieff, and A. Rickinson. 1991. Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 65:1107-1115.
20. Hitt, M. M., C. L. Addison, and F. L. Graham. 1997. Human adenovirus vectors for gene transfer into mammalian cells, p. 138-206. In J. T. August (ed.), Gene therapy. Academic Press, London, United Kingdom.
21. Hockenbery, D., G. Nunez, C. Milliman, R. D. Schreiber, and S. J. Korsmeyer. 1990. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348:334-336.
22. Hotchkiss, R. S., P. E. Swanson, C. M. Knudson, K. C. Chang, J. P. Cobb, D. F. Osborne, K. M. Zollner, T. G. Buchman, S. J. Korsmeyer, and I. E. Karl. 1999. Overexpression of Bcl-2 in transgenic mice decreases apoptosis and improves survival in sepsis. J. Immunol. 162:4148-4156.
23. Ilan, Y., G. Droguett, N. R. Chowdhury, Y. Li, K. Sengupta, N. R. Thummala, A. Davidson, J. R. Chowdhury, and M. S. Horwitz. 1997. Insertion of the adenoviral E3 region into a recombinant viral vector prevents antiviral humoral and cellular immune responses and permits long-term gene expression. Proc. Natl. Acad. Sci. USA 94:2587-2592.
24. Itoh, N., Y. Tsujimoto, and S. Nagata. 1993. Effect of bcl-2 on Fas antigen-mediated cell death. J. Immunol. 151:621-627.
25. Jooss, K., Y. Yang, and J. M. Wilson. 1996. Cyclophosphamide diminishes inflammation and prolongs transgene expression following delivery of adenoviral vectors to mouse liver and lung. Hum. Gene Ther. 7:1555-1566.
26. Kaplan, J. M., J. A. St. George, S. E. Pennington, L. D. Keyes, R. P. Johnson, S. C. Wadsworth, and A. E. Smith. 1996. Humoral and cellular immune responses of nonhuman primates to long-term repeated lung exposure to Ad2/CFTR-2. Gene Ther. 3:117-127.
27. Katsumata, M., R. M. Siegel, D. C. Louie, T. Miyashita, Y. Tsujimoto, P. C. Nowell, M. I. Greene, and J. C. Reed. 1992. Differential effects of Bcl-2 on T and B cells in transgenic mice. Proc. Natl. Acad. Sci. USA 89:11376-11380.
28. Kawahara, A., T. Kobayashi, and S. Nagata. 1998. Inhibition of Fas-induced apoptosis by Bcl-2. Oncogene 17:2549-2554.
29. Kay, M. A., L. Meuse, A. M. Gown, P. Linsley, D. Hollenbaugh, A. Aruffo, H. D. Ochs, and C. B. Wilson. 1997. Transient immunomodulation with anti-CD40 ligand antibody and CTLA41g enhances persistence and secondary adenovirus-mediated gene transfer into mouse liver. Proc. Natl. Acad. Sci. USA 94:4686-4691.
30. Kolls, J. K., D. Lei, G. Odom, S. Nelson, W. R. Summer, M. A. Gerber, and J. E. Shellito. 1996. Use of transient CD4 lymphocyte depletion to prolong transgene expression of El-deleted adenoviral vectors. Hum. Gene Ther. 7:489-497.
31. Koyama, A. H., H. Irie, T. Fukumori, S. Hata, S. Iida, H. Akari, and A. Adachi. 1998. Role of virus-induced apoptosis in a host defense mechanism against virus infection. J. Med. Investig. 45:37-45.
32. Kroemer, G. 1997. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat. Med. 3:614-620. (Erratum, 3:934.)
33. Kurosawa, H., F. G. Que, L. R. Roberts, P. J. Fesmier, and G. J. Gores. 1997. Hepatocytes in the bile duct-ligated rat express Bcl-2. Am. J. Physiol. 272: G1587-G1593.
34. Lacronique, V., A. Mignon, M. Fabre, B. Viollet, N. Rouquet, T. Molina, A. Porteu, A. Henrion, D. Bouscary, P. Varlet, V. Joulin, and A. Kahn. 1996. Bcl-2 protects from lethal hepatic apoptosis induced by an anti-Fas antibody in mice. Nat. Med. 2:80-86.
35. Lawson, J. A., M. A. Fisher, C. A. Simmons, A. Farhood, and H. Jaeschke. 1998. Parenchymal cell apoptosis as a signal for sinusoidal sequestration and transendothelial migration of neutrophils in murine models of endotoxin and Fas-antibody-induced liver injury. Hepatology 28:761-767.
36. Lieber, A., C. Y. He, L. Meuse, C. Himeda, C. Wilson, and M. A. Kay. 1998. Inhibition of NF-κB activation in combination with Bcl-2 expression allows for persistence of first-generation adenovirus vectors in the mouse liver. J. Virol. 72:9267-9277.
37. Lieber, A., C. Y. He, L. Meuse, D. Schowalter, I. Kirillova, B. Winther, and M. A. Kay. 1997. The role of Kupffer cell activation and viral gene expression in early liver toxicity after infusion of recombinant adenovirus vectors. J. Virol. 71:8798-8807.
38. Maher, J. J., and G. J. Gores. 1998. Apoptosis: silent killer or neutron bomb? Hepatology 28:865-867.
39. McFadden, G., K. Graham, and M. Barry. 1996. New strategies of immune modulation by DNA viruses. Transplant. Proc. 28:2085-2088.
40. Meinl, E., H. Fickenscher, M. Thome, J. Tschopp, and B. Fleckenstein. 1998. Anti-apoptotic strategies of lymphotropic viruses. Immunol. Today 19:474-479.
41. Muruve, D. A., M. J. Barnes, I. E. Stillman, and T. A. Libermann. 1999. Adenoviral gene therapy leads to rapid induction of multiple chemokines and acute neutrophil-dependent hepatic injury in vivo. Hum. Gene Ther. 10:965-976.
42. National Institutes of Health. 20 May 1999, last date revised. [Online.] http://www.nih.gov/od/orda/index.htm. [20 May 1999, last date accessed.] National Institutes of Health, Office of Recombinant DNA Activities, Bethesda, Md.
43. Okuyama, T., X. K. Li, N. Funeshima, M. Fujino, K. Sasaki, Y. Kita, M. Kosuga, M. Takahashi, H. Saito, S. Suzuki, and M. Yamada. 1998. Fas-mediated apoptosis is involved in the elimination of gene-transduced hepatocytes with E1/E3-deleted adenoviral vectors. J. Gastroenterol. Hepatol. 13:S113-S118.
44. Peeters, M. J., G. A. Patijn, A. Lieber, L. Meuse, and M. A. Kay. 1996. Adenovirus-mediated hepatic gene transfer in mice: comparison of intravascular and biliary administration. Hum. Gene Ther. 7:1693-1699.
45. Perez, D., and E. White. 1998. E1B 19K inhibits Fas-mediated apoptosis through FADD-dependent sequestration of FLICE. J. Cell Biol. 141:1255-1266.
46. Petrof, B. J., G. Acsadi, A. Jani, B. Massie, J. Bourdon, N. Matusiewicz, L. Yang, H. Lochmuller, and G. Karpati. 1995. Efficiency and functional consequences of adenovirus-mediated in vivo gene transfer to normal and dystrophic (mdx) mouse diaphragm. Am. J. Respir. Cell Mol. Biol. 13:508-517.
47. Pilder, S., J. Logan, and T. Shenk. 1984. Deletion of the gene encoding the adenovirus 5 early region 1b 21,000-molecular-weight polypeptide leads to degradation of viral and host cell DNA. J. Virol. 52:664-671.
48. Qin, L., Y. Ding, D. R. Pahud, N. D. Robson, A. Shaked, and J. S. Bromberg. 1997. Adenovirus-mediated gene transfer of viral interleukin-10 inhibits the immune response to both alloantigen and adenoviral antigen. Hum. Gene Ther. 8:1365-1374.
49. Reed, J. C. 1994. Bcl-2 and the regulation of programmed cell death. J. Cell Biol. 124:1-6.
50. Reed, J. C., H. Zha, C. Aime-Sempe, S. Takayama, and H. G. Wang. 1996. Structure-function analysis of Bcl-2 family proteins. Regulators of programmed cell death. Adv. Exp. Med. Biol. 406:99-112.
51. Rovere, P., A. A. Manfredi, C. Vallinoto, V. S. Zimmermann, U. Fascio, G. Balestrieri, P. Ricciardi-Castagnoli, C. Rugarli, A. Tincani, and M. G. Sabbadini. 1998. Dendritic cells preferentially internalize apoptotic cells opsonized by anti-beta2-glycoprotein 1 antibodies. J. Autoimmun. 11:403-411.
52. Rovere, P., C. Vallinoto, A. Bondanza, M. C. Crosti, M. Rescigno, P. Ricciardi-Castagnoli, C. Rugarli, and A. A. Manfredi. 1998. Bystander apoptosis triggers dendritic cell maturation and antigen-presenting function. J. Immunol. 161:4467-4471.
53. Sato, N., S. Wang, L. Li, K. Okabe, M. Hashimoto, H. Yaginuma, K. Mikoshiba, Y. Uchiyama, T. Uetsuki, K. Yoshikawa, C. E. Milligan, and R. W. Oppenheim. 1998. A novel strategy for introducing exogenous bcl-2 into neuronal cells: the Cre/loxP system-mediated activation of bcl-2 for preventing programmed cell death using recombinant adenoviruses. Mol. Cell. Neurosci. 12:65-78.
54. Schowalter, D. B., J. C. Tubb, M. Liu, C. B. Wilson, and M. A. Kay. 1997. Heterologous expression of adenovirus E3-gp19K in an E1a-deleted adenovirus vector inhibits MHC I expression in vitro, but does not prolong transgene expression in vivo. Gene Ther. 4:351-360.
55. Shen, Y., and T. E. Shenk. 1995. Viruses and apoptosis. Curr. Opin. Genet. Dev. 5:105-111.
56. Shimizu, S., Y. Eguchi, W. Kamiike, Y. Itoh, J. Hasegawa, K. Yamabe, Y. Otsuki, H. Matsuda, and Y. Tsujimoto. 1996. Induction of apoptosis as well as necrosis by hypoxia and predominant prevention of apoptosis by Bcl-2 and Bcl-XL. Cancer Res. 56:2161-2166.
57. Song, W., H. L. Kong, P. Traktman, and R. G. Crystal. 1997. Cytotoxic T lymphocyte responses to proteins encoded by heterologous transgenes transferred in vivo by adenoviral vectors. Hum. Gene Ther. 8:1207-1217.
58. Spriggs, M. K. 1996. One step ahead of the game: viral immunomodulatory molecules. Annu. Rev. Immunol. 14:101-130.
59. Sullivan, D. E., S. Dash, H. Du, N. Hiramatsu, F. Aydin, J. Kolls, J. Blanchard, G. Baskin, and M. A. Gerber. 1997. Liver-directed gene transfer in non-human primates. Hum. Gene Ther. 8:1195-1206.
60. Takemori, N., C. Cladaras, B. Bhat, A. J. Conley, and W. S. Wold. 1984. cyt gene of adenoviruses 2 and 5 is an oncogene for transforming function in early region E1B and encodes the E1B 19,000-molecular-weight polypeptide. J. Virol. 52:793-805.
61. Taub, R. 1998. Blocking NF-kappaB in the liver: the good and bad news. Hepatology 27:1445-1446.
62. Thompson, C. B. 1995. Apoptosis in the pathogenesis and treatment of disease. Science 267:1456-1462.
63. Tripathy, S. K., H. B. Black, E. Goldwasser, and J. M. Leiden. 1996. Immune responses to transgene-encoded proteins limit the stability to gene expression after injection of replication-defective adenovirus vectors. Nat. Med. 2:545-555.
64. Tsujimoto, Y., J. Gorham, J. Cossman, E. Jaffe, and C. M. Croce. 1985. The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. Science 229:1390-1393.
65. van Ginkel, F. W., J. R. McGhee, C. Liu, J. W. Simecka, M. Yamamoto, R. A. Frizzell, E. J. Somber, H. Kiyono, and D. W. Pascual. 1997. Adenoviral gene delivery elicits distinct pulmonary-associated T helper cell responses to the vector and to its transgene. J. Immunol. 159:685-693.
66. Vaux, D. L., and A. Strasser. 1996. The molecular biology of apoptosis. Proc. Natl. Acad. Sci. USA 93:2239-2244.
67. Vrancken Peeters, M. J., A. L. Perkins, and M. A. Kay. 1996. Method for multiple portal vein infusions in mice: quantitation of adenovirus-mediated hepatic gene transfer. BioTechniques 20:278-285.
68. White, E. 1996. Life, death, and the pursuit of apoptosis. Genes Dev. 10:1-15.
69. White, E., T. Grodzicker, and B. W. Stillman. 1984. Mutations in the gene encoding the adenovirus early region 1B 19,000-molecular-weight tumor antigen cause the degradation of chromosomal DNA. J. Virol. 52:410-419.
70. Wilson, J. M. 1995. Gene therapy for cystic fibrosis: challenges and future directions. J. Clin. Investig. 96:2547-2554.
71. Worgall, S., P. L. Leopold, G. Wolff, B. Ferris, R. N. Van, and R. G. Crystal. 1997. Role of alveolar macrophages in rapid elimination of adenovirus vectors administered to the epithelial surface of the respiratory tract. Hum. Gene Ther. 8:1675-1684.
72. Worgall, S., G. Wolff, E. Falck-Pedersen, and R. G. Crystal. 1997. Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration. Hum. Gene Ther. 8:37-44.
73. Yamabe, K., S. Shimizu, W. Kamiike, S. Waguri, Y. Eguchi, J. Hasegawa, S. Okudo, Y. Yoshioka, T. Ito, Y. Sawa, Y. Uchiyama, Y. Tsujimoto, and H. Matsuda. 1998. Prevention of hypoxic liver cell necrosis by in vivo human bcl-2 gene transfection. Biochem. Biophys. Res. Commun. 243:217-223.
74. Yang, L., R. T. Matthews, J. B. Schulz, T. Klockgether, A. W. Liao, J. C. Martinou, J. B. J. Penney, B. T. Hyman, and M. F. Beal. 1998. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyride neurotoxicity is attenuated in mice overexpressing Bcl-2. J. Neurosci. 18:8145-8152.
75. Yang, Y., H. C. Ertl, and J. M. Wilson. 1994. MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity 1:433-442.
76. Yang, Y., S. E. Haecker, Q. Su, and J. M. Wilson. 1996. Immunology of gene therapy with adenoviral vectors in mouse skeletal muscle. Hum. Mol. Genet. 5:1703-1712.
77. Yang, Y., K. U. Jooss, Q. Su, H. C. Ertl, and J. M. Wilson. 1996. Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo. Gene Ther. 3:137-144.
78. Yang, Y., Z. Xiang, H. C. Ertl, and J. M. Wilson. 1995. Upregulation of class I major histocompatibility complex antigens by interferon gamma is necessary for T-cell-mediated elimination of recombinant adenovirus-infected hepatocytes in vivo. Proc. Natl. Acad. Sci. USA 92:7257-7261.
79. Zhang, H. G., G. Bilbao, T. Zhou, J. L. Contreras, J. Gomez-Navarro, M. Feng, I. Saito, J. D. Mountz, and D. T. Curiel. 1998. Application of a Fas ligand encoding a recombinant adenovirus vector for prolongation of transgene expression. J. Virol. 72:2483-2490.
80. Zhang, H. G., T. Zhou, P. Yang, C. K. Edwards, D. T. Curiel, and J. D. Mountz. 1998. Inhibition of tumor necrosis factor alpha decreases inflammation and prolongs adenovirus gene expression in lung and liver. Hum. Gene Ther. 9:1875-1884.
81. Zhong, L. T., T. Sarafian, D. J. Kane, A. C. Charles, S. P. Mah, R. H. Edwards, and D. E. Bredesen. 1993. bcl-2 inhibits death of central neural cells induced by multiple agents. Proc. Natl. Acad. Sci. USA 90:4533-4537.
82. Zhu, H., Y. Shen, and T. Shenk. 1995. Human cytomegalovirus IE1 and IE2 proteins block apoptosis. J. Virol. 69:7960-7970.